Print ISSN: 2394-2746
Online ISSN: 2394-2754
CODEN : IJOGCS
Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...Case Report
Author Details :
Volume : 6, Issue : 2, Year : 2019
Article Page : 233-236
https://doi.org/10.18231/j.ijogr.2019.054
Abstract
Objective: To report a case of cervical ectopic managed by intra-cardiac injection of potassium chloride to terminate pregnancy.
Design: Case Report .
Patient: A 24-year-old G2P1+0, presented with vaginal bleeding. Cervical pregnancy (7 weeks+4 days) was diagnosed by transvaginal ultrasound.
Intervention: Intra-cardiac injection of (KCL) was done plus intra-amniotic injection of methotrexate under ultrasound guidance.
Outcomes: Safe pregnancy termination and uterine preservation.
Results: Pregnancy was terminated successfully, without complications or side effects.
Conclusion: Intra-cardiac injection of KCL appears to be an effective and safe method in termination of cervical ectopic pregnancy less than 10 weeks.
Keywords: Cervical ectopic, Intra-cardiac feticide, Potassium Chloride, Methotrexate.
How to cite : Dawood A S, Farahat M A, Intra-cardiac feticide injection for cervical ectopic pregnancy less than 10 weeks of gestation: A case report and review of literature. Indian J Obstet Gynecol Res 2019;6(2):233-236
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.